Your browser doesn't support javascript.
loading
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
Parker, Edward P K; Desai, Shalini; Marti, Melanie; O'Brien, Katherine L; Kaslow, David C; Kochhar, Sonali; Olayinka, Folake; Cravioto, Alejandro; Nohynek, Hanna; Hombach, Joachim; Wilder-Smith, Annelies.
Afiliação
  • Parker EPK; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland; The Vaccine Centre, London School of Hygiene &Tropical Medicine, London, UK. Electronic address: edward.parker@lshtm.ac.uk.
  • Desai S; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • Marti M; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • O'Brien KL; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • Kaslow DC; PATH Essential Medicines, PATH, Seattle, WA, USA.
  • Kochhar S; Global Healthcare Consulting, New Delhi, India; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Olayinka F; STAR Program, Public Health Institute, Washington DC, USA.
  • Cravioto A; Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Nohynek H; Department of Health Security at the Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Hombach J; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • Wilder-Smith A; Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland; Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Lancet Infect Dis ; 22(4): 438-440, 2022 04.
Article em En | MEDLINE | ID: mdl-35278358

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article